4//SEC Filing
Smith Thomas B 4
Accession 0001062993-24-016699
CIK 0001267565other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 4:32 PM ET
Size
5.1 KB
Accession
0001062993-24-016699
Insider Transaction Report
Form 4
Smith Thomas B
EVP and Chief Medical Officer
Transactions
- Sale
Common Stock
2024-09-13$36.62/sh−9,593$351,320→ 53,816 total
Footnotes (1)
- [F1]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.56 to $36.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001748462
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 4:32 PM ET
- Size
- 5.1 KB